BR0113745A - Vacina, teste diagnóstico e métodos para imunizar mamìferos e para preparar uma vacina - Google Patents

Vacina, teste diagnóstico e métodos para imunizar mamìferos e para preparar uma vacina

Info

Publication number
BR0113745A
BR0113745A BR0113745-0A BR0113745A BR0113745A BR 0113745 A BR0113745 A BR 0113745A BR 0113745 A BR0113745 A BR 0113745A BR 0113745 A BR0113745 A BR 0113745A
Authority
BR
Brazil
Prior art keywords
vaccine
methods
preparing
diagnostic test
immunizing mammals
Prior art date
Application number
BR0113745-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Ronald C Montelaro
Jodi Craigo
Charles Issel
Bridget Puffer
Kristina J Hennessey
Karen K Brown
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR0113745A publication Critical patent/BR0113745A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR0113745-0A 2000-09-09 2001-09-06 Vacina, teste diagnóstico e métodos para imunizar mamìferos e para preparar uma vacina BR0113745A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65902900A 2000-09-09 2000-09-09
PCT/US2001/027599 WO2002020049A2 (en) 2000-09-09 2001-09-06 Eiav chimeric vaccine and diagnostic

Publications (1)

Publication Number Publication Date
BR0113745A true BR0113745A (pt) 2004-03-02

Family

ID=24643739

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113745-0A BR0113745A (pt) 2000-09-09 2001-09-06 Vacina, teste diagnóstico e métodos para imunizar mamìferos e para preparar uma vacina

Country Status (5)

Country Link
EP (1) EP1345622A2 (enExample)
JP (1) JP2004522697A (enExample)
AU (2) AU8710301A (enExample)
BR (1) BR0113745A (enExample)
WO (1) WO2002020049A2 (enExample)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873690A (en) * 1974-01-23 1975-03-25 Iii James H Rand Equine infectious anemia vaccine
US5614404A (en) * 1988-06-10 1997-03-25 Theriod Biologics, Incorporated Self-assembled, defective, non-self-propagating lentivirus particles
US5955342A (en) * 1994-08-15 1999-09-21 Connaught Laboratories Limited Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
AU7332198A (en) * 1997-03-06 1998-09-22 Klaus Uberla Lentivirus based vector and vector system
KR100556864B1 (ko) * 1997-05-13 2006-03-10 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 렌티바이러스-기원 유전자 전달 벡터
DK1895010T3 (da) * 1997-12-22 2011-11-21 Oxford Biomedica Ltd Vektorer baseret på virus for infektiøs hesteanæmi (eiav)
CN1173036C (zh) * 1999-04-21 2004-10-27 卫生部艾滋病预防与控制中心 马传染性贫血病毒驴白细胞弱毒疫苗株的全长基因序列

Also Published As

Publication number Publication date
WO2002020049A3 (en) 2003-07-03
EP1345622A2 (en) 2003-09-24
AU8710301A (en) 2002-03-22
AU2001287103B2 (en) 2007-02-01
JP2004522697A (ja) 2004-07-29
WO2002020049A2 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
Mondal et al. Maternal antibody to infectious bronchitis virus: its role in protection against infection and development of active immunity to vaccine
Tarradas et al. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs
ATE131067T1 (de) Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei schweinen (prrs) und diagnose.
McFerran et al. Further studies on the classification of fowl adenoviruses
Jensen New set of type A influenza viruses
Fulton et al. Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay
WO2015056850A1 (ko) 돼지 생식기 호흡기 증후군 바이러스의 키메릭 변이주
BR0113745A (pt) Vacina, teste diagnóstico e métodos para imunizar mamìferos e para preparar uma vacina
Jackwood Viral competition and maternal immunity influence the clinical disease caused by very virulent infectious bursal disease virus
Barrera et al. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats
HUP0402098A2 (hu) Baromfibetegségeket okozó új baktérium és ebből származó vakcina
CZ20022554A3 (cs) ®ivý oslabený virus PRRS, nukleotidová sekvence a farmaceutický prostředek
Baipoledi et al. Re-emergence of foot-and-mouth disease in Botswana
Escorcia et al. Characterization of Mexican strains of avian infectious bronchitis isolated during 1997
Taberner et al. Efficacy of vaccination with the DIVENCE® vaccine against bovine viral diarrhea virus types 1 and 2 in terms of fetal protection
BR0308620A (pt) Fragmentos de antìgenos para a diagnose de toxoplasma gondii
Kulcsar et al. Pathogenicity of a bovine viral diarrhoea virus strain in pregnant sows
Kim et al. Characterization of encephalomyocarditis virus isolated from aborted swine fetuses
Selleck et al. Rapid diagnosis of highly pathogenic avian influenza using pancreatic impression smears
Khan et al. Application of saliva in COVID-19 diagnosis: Challenges and opportunities
Ghorani et al. Detection of avian encephalomyelitis virus in broiler chickens in Iran using RT-PCR and histopathological methods
House et al. Characteristics of the porcine kidney cell line IB-RS-2 clone D10 (IB-RS-2 D10) which is free of hog cholera virus
Sander et al. Protection by a commercial Arkansas-type infectious bronchitis virus vaccine against a field isolate of the same serotype
Becerra et al. Studies on the response of ewes to live chlamydiae adapted to chicken embryos or tissue culture
DiGiacomo et al. Impact of herd additions on bovine leukosis virus infection in a commercial dairy herd.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: INTERVET INTERNATIONAL B.V. (NL)

Free format text: TRANSFERIDO DE: AKZO NOBEL N.V.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: ANALISANDO-SE O PROCESSO REFERENTE AO PEDIDO PI0113745-0 , OBSERVA-SE QUE NAO FORAM APRESENTADOS DOCUMENTOS DE CESSAO DOS DIREITOS RELATIVOS AOS DOCUMENTOS DE PRIORIDADE PARA QUATRO INVENTORES DO PEDIDO. SOMENTE SE OBSERVA DOCUMENTO DE CESSAO OS DIREITOS RELATIVOS AOS DOCUMENTOS DE PRIORIDADE PARA DOIS INVENTORES (KRISTINA J. HENNESSEY E KAREN K. BROWN) ATRAVES DA PETICAO NO023842 DE 06/05/2003. DESTE MODO, A REQUERENTE DEVERA, PARA QUE SE DE INICIO AO EXAME, APRESENTAR COPIA DOS REFERIDOS DOCUMENTOS, SANANDO TAL IRREGULARIDADE.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2166 DE 10/07/2012.